Management of allergic disease in the elderly: Key considerations, recommendations and emerging therapies

Nicola Scichilone, Erminia Ridolo, Vincenzo Patella, Maria Teresa Ventura, Matteo Gelardi

Risultato della ricerca: Article

19 Citazioni (Scopus)

Abstract

The number of people over 65 is increasing around the world. At present, between 5 and 10% of allergic diseases affect the elderly. In particular, rhinitis is increasing worldwide; the presence of high comorbidity makes the therapy of asthma even more complicated. With reference to dermatological allergies, the dryness of the skin favors the onset of allergic contact and atopic dermatitis, while the senescence of mucous membranes and the impaired secretion of polymeric IgA could be linked to food allergy. Overcoming the problem of adverse drug reaction is limited by the diagnostic difficulty in patients taking multiple drugs. In addition, some drugs, such as β-blockers, angiotensin-converting enzyme (ACE)-inhibitors and NSAIDs, are relevant factors of urticaria and anaphylaxis. The aim of this review is to provide updated diagnostic and therapeutic guidelines through a better understanding of the pathophysiologic mechanisms, preventive measures and adherence to therapy.
Lingua originaleEnglish
pagine (da-a)1219-1228
Numero di pagine10
RivistaExpert Review of Clinical Immunology
Volume11
Stato di pubblicazionePublished - 2015

Fingerprint

Disease Management
Allergic Contact Dermatitis
Food Hypersensitivity
Urticaria
Anaphylaxis
Non-Steroidal Anti-Inflammatory Agents
Atopic Dermatitis
Rhinitis
Drug-Related Side Effects and Adverse Reactions
Angiotensin-Converting Enzyme Inhibitors
Pharmaceutical Preparations
Comorbidity
Hypersensitivity
Mucous Membrane
Therapeutics
Asthma
Guidelines
Skin

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cita questo

Management of allergic disease in the elderly: Key considerations, recommendations and emerging therapies. / Scichilone, Nicola; Ridolo, Erminia; Patella, Vincenzo; Ventura, Maria Teresa; Gelardi, Matteo.

In: Expert Review of Clinical Immunology, Vol. 11, 2015, pag. 1219-1228.

Risultato della ricerca: Article

Scichilone, Nicola ; Ridolo, Erminia ; Patella, Vincenzo ; Ventura, Maria Teresa ; Gelardi, Matteo. / Management of allergic disease in the elderly: Key considerations, recommendations and emerging therapies. In: Expert Review of Clinical Immunology. 2015 ; Vol. 11. pagg. 1219-1228.
@article{62a733af6f7d4b0ab811ca7c1980fa2c,
title = "Management of allergic disease in the elderly: Key considerations, recommendations and emerging therapies",
abstract = "The number of people over 65 is increasing around the world. At present, between 5 and 10{\%} of allergic diseases affect the elderly. In particular, rhinitis is increasing worldwide; the presence of high comorbidity makes the therapy of asthma even more complicated. With reference to dermatological allergies, the dryness of the skin favors the onset of allergic contact and atopic dermatitis, while the senescence of mucous membranes and the impaired secretion of polymeric IgA could be linked to food allergy. Overcoming the problem of adverse drug reaction is limited by the diagnostic difficulty in patients taking multiple drugs. In addition, some drugs, such as β-blockers, angiotensin-converting enzyme (ACE)-inhibitors and NSAIDs, are relevant factors of urticaria and anaphylaxis. The aim of this review is to provide updated diagnostic and therapeutic guidelines through a better understanding of the pathophysiologic mechanisms, preventive measures and adherence to therapy.",
author = "Nicola Scichilone and Erminia Ridolo and Vincenzo Patella and Ventura, {Maria Teresa} and Matteo Gelardi",
year = "2015",
language = "English",
volume = "11",
pages = "1219--1228",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",

}

TY - JOUR

T1 - Management of allergic disease in the elderly: Key considerations, recommendations and emerging therapies

AU - Scichilone, Nicola

AU - Ridolo, Erminia

AU - Patella, Vincenzo

AU - Ventura, Maria Teresa

AU - Gelardi, Matteo

PY - 2015

Y1 - 2015

N2 - The number of people over 65 is increasing around the world. At present, between 5 and 10% of allergic diseases affect the elderly. In particular, rhinitis is increasing worldwide; the presence of high comorbidity makes the therapy of asthma even more complicated. With reference to dermatological allergies, the dryness of the skin favors the onset of allergic contact and atopic dermatitis, while the senescence of mucous membranes and the impaired secretion of polymeric IgA could be linked to food allergy. Overcoming the problem of adverse drug reaction is limited by the diagnostic difficulty in patients taking multiple drugs. In addition, some drugs, such as β-blockers, angiotensin-converting enzyme (ACE)-inhibitors and NSAIDs, are relevant factors of urticaria and anaphylaxis. The aim of this review is to provide updated diagnostic and therapeutic guidelines through a better understanding of the pathophysiologic mechanisms, preventive measures and adherence to therapy.

AB - The number of people over 65 is increasing around the world. At present, between 5 and 10% of allergic diseases affect the elderly. In particular, rhinitis is increasing worldwide; the presence of high comorbidity makes the therapy of asthma even more complicated. With reference to dermatological allergies, the dryness of the skin favors the onset of allergic contact and atopic dermatitis, while the senescence of mucous membranes and the impaired secretion of polymeric IgA could be linked to food allergy. Overcoming the problem of adverse drug reaction is limited by the diagnostic difficulty in patients taking multiple drugs. In addition, some drugs, such as β-blockers, angiotensin-converting enzyme (ACE)-inhibitors and NSAIDs, are relevant factors of urticaria and anaphylaxis. The aim of this review is to provide updated diagnostic and therapeutic guidelines through a better understanding of the pathophysiologic mechanisms, preventive measures and adherence to therapy.

UR - http://hdl.handle.net/10447/209043

M3 - Article

VL - 11

SP - 1219

EP - 1228

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

ER -